Cargando…

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD

BACKGROUND: There is a lack of data comparing azithromycin to alternative antibiotic choices in managing COPD exacerbations, making appropriate antibiotic selection controversial. OBJECTIVE: To compare treatment failure in hospitalized patients with acute exacerbations of chronic obstructive pulmona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baalbaki, Nour, Giuliano, Christopher, Hartner, Carrie L., Kale-Pradhan, Pramodini, Johnson, Leonard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939242/ https://www.ncbi.nlm.nih.gov/pubmed/35316516 http://dx.doi.org/10.1007/s11606-022-07486-5

Ejemplares similares

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

Vulnerable COPD patients with comorbidities: the role of roflumilast
por: Lipari, Melissa, et al.
Publicado: (2014)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

1386. Prescribing Patterns of Skin and Soft Tissue Infections in Patients Discharged from the Emergency Department
por: Feist, Jacqueline, et al.
Publicado: (2022)

2428. Lower Rates of Antibiotic Treatment of Vancomycin-Resistant Compared With Vancomycin Susceptible Enterococcal Bacteriuria
por: Vendittelli, Bridget, et al.
Publicado: (2018)

Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
por: Al-Salloum, Jumana, et al.
Publicado: (2021)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

2008. Outcomes of Patients with Positive Procalcitonin Levels Who Do Not Receive Continued Antibiotics
por: George, Jamie, et al.
Publicado: (2019)

49. Clinical Utility of Oseltamivir Restriction Policy
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2020)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

Insulin Detemir Versus Insulin Glargine in the Hospital: Do Hypoglycemia Rates Differ?
por: Crisher, Michelle A., et al.
Publicado: (2019)

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
por: Pomares, Xavier, et al.
Publicado: (2011)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

1469. Effect of Treatment Duration on Outcomes in Septic Patients Admitted for Urinary Tract Infections from Extended Care Facilities
por: Jongekrijg, Annelise, et al.
Publicado: (2019)

556. Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19
por: Berti, Andrew David, et al.
Publicado: (2020)

Adverse drug reactions in drug information databases: does presentation affect interpretation?
por: McConachie, Sean M., et al.
Publicado: (2020)

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2019)

579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2023)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
por: Charriot, Jeremy, et al.
Publicado: (2023)

Azithromycin: Exacerbation of diaphragm hemiparesis: case report
Publicado: (2020)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man
por: Berry, Angela V., et al.
Publicado: (2022)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

Endopeptidase-Mediated Beta Lactam Tolerance
por: Dörr, Tobias, et al.
Publicado: (2015)

Profile of Enterobacteria Resistant to Beta-Lactams
por: Santos, Andressa Liberal, et al.
Publicado: (2020)

The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2016)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
por: López-Campos, Jose Luis, et al.
Publicado: (2015)

Predicting and preventing hospital readmission for exacerbations of COPD
por: Kong, Chia Wei, et al.
Publicado: (2020)

Comparative Effectiveness of β-lactams Vs Azithromycin for Treatment of Outpatient Pediatric Community-acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
por: Lin, Chieh-Mo, et al.
Publicado: (2020)

Beta-lactam allergy in Chinese patients and factors predicting genuine allergy
por: Li, Philip Hei, et al.
Publicado: (2019)

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit
por: Ruparel, Mamta, et al.
Publicado: (2016)

THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective
Publicado: (1980)

Beta-lactam hypersensitivity: not always what it seems
por: Andrade, Djanira, et al.
Publicado: (2015)

Use of beta-lactams antibiotics in ICU patients
por: Damas, M-P, et al.
Publicado: (2015)

Dual beta-lactam treatment: Pros and cons
por: Guerra, Diogo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v89vkrtco0pf4gmguhq4cd0s7